Biosimilars are complex biologic drugs that mimic original treatments but can't be exact copies due to their living-cell production. Manufacturing them requires mastering glycosylation, scaling up without losing quality, and navigating strict global regulations-all while keeping costs under control.
Acromegaly is a rare hormonal disorder caused by excess growth hormone in adults, leading to physical changes and serious health risks. Learn how it's diagnosed, treated, and why early intervention saves lives.
Corticosteroid injections can quickly reduce joint inflammation and pain, but they're not a cure. Learn how they work, who benefits most, how many are safe, and the real risks behind the relief.
Steroid-induced psychosis is a dangerous but treatable side effect of high-dose corticosteroids. Recognizing early signs like agitation and confusion within days of starting treatment can prevent full-blown psychosis. Tapering the steroid and using low-dose antipsychotics leads to recovery in over 90% of cases.
Vaccines for immunosuppressed patients require precise timing to work. Learn how medications like rituximab and methotrexate affect vaccine response and what the latest guidelines say about when to get protected.
Repeated antibiotic use fuels drug-resistant bacteria, leading to longer illnesses, higher death rates, and fewer treatment options. Learn how this silent pandemic is reshaping modern medicine-and what you can do to help.
The FDA ensures generic drugs are as safe and effective as brand-name drugs through the ANDA process. Learn how bioequivalence, manufacturing standards, and regulatory timelines make generics a trusted, low-cost option for millions.
OTC sleep aids like diphenhydramine and melatonin offer temporary help for occasional insomnia, but they come with real risks - including dementia, falls, and rebound sleep problems. Learn what works, what doesn’t, and how to use them safely.
Generic prescription copays don’t count toward your health insurance deductible-but they do count toward your out-of-pocket maximum. Learn how this works, why it matters, and how to avoid costly misunderstandings.
The ANDA process enables generic drug approval in the U.S. by requiring bioequivalence, identical formulation, and strict manufacturing standards under the Hatch-Waxman Act. It has saved consumers over $2.2 trillion since 2013.